Overview

A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants

Status:
Recruiting
Trial end date:
2024-02-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioavailability of two different doses of venetoclax new high drug load formulation tablets relative to two tablets of the currently marketed venetoclax tablets under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
AbbVie
Treatments:
Venetoclax